Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 2/20 | 0.39 |
| ▸ | NQO2 | P16083 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | KDM4D | Q6B0I6 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1908710 | 0.87 | — | — | |
| SCHEMBL12090531 | 0.86 | POLB (0.52) | POLBALDH1A1MAPTCA2CA1 | |
| SCHEMBL147224 | 0.86 | — | — | |
| SCHEMBL3421764 | 0.85 | — | — | |
| Hydrochloric Acid SCHEMBL16990399 | 0.85 | POLB (0.38) | POLBALDH1A1MAPTCA2CA1 | |
| SCHEMBL19303352 | 0.85 | POLB (0.38) | POLBALDH1A1MAPTCA2CA1 | |
| SCHEMBL14739086 | 0.83 | GRIA1 (0.52) | POLBALDH1A1CA2CA1CA12 | |
| SCHEMBL14739265 | 0.83 | GRIA1 (0.52) | POLBALDH1A1CA2CA1CA12 | |
| SCHEMBL14740061 | 0.83 | GRIA1 (0.52) | POLBALDH1A1CA2CA1CA12 | |
| SCHEMBL736693 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0213793-B1 | SULPHONAMIDES | JOHN WYETH & BROTHER LIMITED (GB) | 1992-03-18 | — | — | EP | claimed |
| CN-111403809-B | Additive for lithium secondary battery, electrolyte and lithium secondary battery comprising same | 三星SDI株式会社 | 2023-08-18 | — | — | CN | disclosed |
| US-11329318-B2 | Electrolyte additive for lithium secondary battery and lithium secondary battery including the same | SAMSUNG SDI CO., LTD. (KR) | 2022-05-10 | — | — | US | disclosed |
| CN-111403809-A | Additive for lithium secondary battery, electrolyte and lithium secondary battery comprising same | 三星SDI株式会社 | 2020-07-10 | — | — | CN | disclosed |
| US-20200220217-A1 | ELECTROLYTE ADDITIVE FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2020-07-09 | — | — | US | disclosed |
| WO-2018152438-A1 | AMINE-APPENDED METAL-ORGANIC FRAMEWORKS EXHIBITING A NEW ADSORPTION MECHANISM FOR CARBON DIOXIDE SEPARATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-08-23 | — | — | WO | disclosed |
| US-20140176653-A1 | NOVEL COMPOUND HAVING MULTIMER STRUCTURE OF XANTHENE DERIVATIVE, COLORING COMPOSITION, INK FOR INKJET RECORDING, METHOD OF INKJET RECORDING, COLOR FILTER, AND COLOR TONER | FUJIFILM CORPORATION (JP) | 2014-06-26 | — | — | US | disclosed |
| WO-2014075648-A1 | A METHOD OF PREPARING APIXABAN | ZENTIVA, K.S. (CZ) | 2014-05-22 | — | — | WO | disclosed |
| US-8563679-B2 | Catalytic systems for the ring-opening (co)polymerization of lactones | IPSEN PHARMA S.A.S. (FR) | 2013-10-22 | — | — | US | disclosed |
| US-8440417-B2 | Method for assaying compounds or agents for ability to displace potent ligands of hematopoietic prostaglandin D synthase | CAYMAN CHEMICAL COMPANY, INCORPORATED (US) | 2013-05-14 | — | — | US | disclosed |
| US-20110054144-A1 | NOVEL CATALYTIC SYSTEMS FOR THE RING-OPENING (CO)POLYMERIZATION OF LACTONES | IPSEN PHARMA S.A.S. (FR) | 2011-03-03 | — | — | US | disclosed |
| US-7763747-B2 | Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; Alzheimer's disease; diabetes; A beta amyloidosis | PROTEOTECH, INC. (US) | 2010-07-27 | — | — | US | disclosed |
| WO-2009138589-A1 | NOVEL CATALYTIC SYSTEMS FOR THE RING-OPENING (CO)POLYMERIZATION OF LACTONES | IPSEN PHARMA S.A.S. (FR) | 2009-11-19 | — | — | WO | disclosed |
| WO-2009140364-A2 | METHODS FOR ASSAYING COMPOUNDS OR AGENTS FOR ABILITY TO DISPLACE POTENT LIGANDS OF HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE | CAYMAN CHEMICAL COMPANY (US) | 2009-11-19 | — | — | WO | disclosed |
| US-20090069432-A1 | Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; Alzheimer's disease; diabetes; A beta amyloidosis | PROTEOTECH INC. | 2009-03-12 | — | — | US | disclosed |
| WO-2007091950-A1 | BENZIMIDAZOLES AND IMIDAZOPYRIDINES USEFUL IN THE TREATMENT OF DISEASES OR DISORDERS ASSOCIATED WITH CANNABINOID RECEPTOR 2 (CB2) SUCH AS PAIN | ASTRAZENECA AB (SE) | 2007-08-16 | — | — | WO | disclosed |
| EP-1713796-A1 | PROCESS FOR PREPARING SUBSTITUTED BENZOPYRAN COMPOUNDS | SK CHEMICALS CO., LTD. (KR) | 2006-10-25 | — | — | EP | disclosed |
| WO-2005077942-A1 | PROCESS FOR PREPARING SUBSTITUTED BENZOPYRAN COMPOUNDS | SK CHEMICALS, CO., LTD. (KR) | 2005-08-25 | — | — | WO | disclosed |
| WO-1992012187-A1 | CHIRAL POLYMERS, THEIR PREPARATION AND USE IN PREPARING OPTICALLY ACTIVE PROPIONIC 2-ARYL ACIDS | RHONE-POULENC RORER S.A. (FR) | 1992-07-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110054144-A1 | NOVEL CATALYTIC SYSTEMS FOR THE RING-OPENING (CO)POLYMERIZATION OF LACTONES | COASY, STS, SQOR | POLB 1336/4885ALDH1A1 1772/4885MAPT 3312/4885 |
| US-20200220217-A1 | ELECTROLYTE ADDITIVE FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING THE SAME | SLC26A3, SLC9A1, SLC9B2 | POLB 203/4885ALDH1A1 244/4885MAPT 1525/4885 |
| US-11329318-B2 | Electrolyte additive for lithium secondary battery and lithium secondary battery including the same | SLC26A3, SLC9A1, SLC9B2 | POLB 203/4885ALDH1A1 244/4885MAPT 1525/4885 |
| US-20090069432-A1 | Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; Alzheimer's disease; diabetes; A beta amyloidosis | IAPP, APP, SNCA | POLB 1672/4885ALDH1A1 2505/4885MAPT 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.